Prevalence of hereditary factors in different age groups in patients with acute coronary syndrome

Abstract

BACKGROUND: Genetic factors are essential for the pathogenesis of coronary heart disease (CHD). This study presents the role of genetic factors in a prematurely developing disease in males under 55 years old and females under 60 years old. Additionally, genetic risk factors may also be significant for CHD development in other age groups although specific genetic factors may differ.

AIM: The work aimed to analyze the prevalence of hereditary genetic factors in different age groups in patients with coronary heart disease.

MATERIALS AND METHODS: The study was conducted as part of the analysis of data from two observational multicenter Russian studies of acute coronary syndrome (ACS) ORACUL I (1193 patients) and ORACUL II (1803 patients) (the study was registered on ClinicalTrials.gov with an ID number NCT04068909). The average age of patients was 63.5±12.45 years (1875 men and 1121 women). The study of a panel of candidate genes was performed using the polymerase chain reaction method.

RESULTS: In order to analyze the significance of hereditary factors in patients of different ages, groups of patients with “early” development of CHD (men under 55 years old, women under 60 years old) were formed (n=828). The middle-aged group included men aged 55–74 years and women aged 60–74 years (n=1410). The older age group consisted of patients aged 75 years and older (n=602). In the group of patients with early onset coronary heart disease, the proportion of patients with aggravated heredity was higher. In the older age group, the proportion of patients with non-burdened or unknown heredity was higher. Significant differences in the frequencies of alleles and genotypes of the polymorphic variants studied by us were revealed only for the G-2667C variant of the CRP gene (the frequency of the GG genotype was 87.3% in young patients and 77.2% in the elderly and old patients (p=0.007) and for the C804A variant of the LTA gene (frequency of the CC genotype was 52 0% in young patients, 49.4% in middle-aged patients, and 34.2% in elderly and old patients, p=0.026).

CONCLUSIONS: A burdened family history is more common among patients with early onset coronary artery disease. The differences revealed in the frequencies of genetic variants of genes encoding anti-inflammatory cytokines may indicate their role in the pathogenesis of coronary heart disease in older individuals.

Keywords

acute coronary syndrome / heredity / candidate gene / pro-inflammatory cytokines

References

[1] Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188. doi: 10.1093/eurheartj/ehz455

[2] Mach F., Baigent C., Catapano A.L., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk // Eur Heart J. 2020. Vol. 41, N 1. P. 111–188. doi: 10.1093/eurheartj/ehz455

[3] Averkova A, Brazhnik V, Koroleva O, et al. Acute coronary syndrome in young patients with familial hyperchoolesterolemia based on the results of Oracul II observation trial. Medical News of the North Caucasus. 2017;12(1). (In Russ). doi: 10.14300/mnnc.2017.12001

[4] Аверкова А.О., Бражник В.А., Королева О.С., и др. Особенности течения острого коронарного синдрома у молодых больных с семейной гиперлипидемией по данным наблюдательного проекта оракул II // Медицинский вестник Северного Кавказа. 2017. Т. 12, № 1. C. 5–7. doi: 10.14300/mnnc.2017.12001

[5] Zateyshchikov DA, Volkova EG, Guz IO, et al. Treatment of patients underwent acute coronary syndrome according to the data of Russian multicentral prospective observational study. Farmateca. 2009;(12):109–113. (In Russ).

[6] Затейщиков Д.А., Волкова Э.Г., Гузь И.О., и др. Лечение больных, перенесших острый коронарный синдром, по данным Российского многоцентрового проспективного наблюдательного исследования // Фарматека. 2009. № 12. С. 109–113.

[7] Konig M, Joshi S, Leistner DM, et al. Cohort profile: role of lipoproteins in cardiovascular disease-the LipidCardio study. BMJ Open. 2019;9(9):e030097. doi: 10.1136/bmjopen-2019-030097

[8] Konig M., Joshi S., Leistner D.M., et al. Cohort profile: role of lipoproteins in cardiovascular disease-the LipidCardio study // BMJ Open. 2019. Vol. 9, N 9. P. e030097. doi: 10.1136/bmjopen-2019-030097

[9] Hameed H, Faryal M, Aslam MA, et al. Association of Polymorphisms (rs 1799782, rs25489 and rs25487) in XRCC1 and (rs 13181) XPD genes with Acute Coronary Artery Syndrome in Subjects from Multan, Pakistan. Pak J Pharm Sci. 2016;29(3):869–876.

[10] Hameed H., Faryal M., Aslam M.A., et al. Association of Polymorphisms (rs 1799782, rs25489 and rs25487) in XRCC1 and (rs 13181) XPD genes with Acute Coronary Artery Syndrome in Subjects from Multan, Pakistan // Pak J Pharm Sci. 2016. Vol. 29, N 3. P. 869–876.

[11] Tikkanen E, Havulinna AS, Palotie A, et al. Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease. Arterioscler Thromb Vasc Biol. 2013;33(9):2261–2266. doi: 10.1161/ATVBAHA.112.301120

[12] Tikkanen E., Havulinna A.S., Palotie A., et al. Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease // Arterioscler Thromb Vasc Biol. 2013. Vol. 33, N 9. P. 2261–2266. doi: 10.1161/ATVBAHA.112.301120

[13] Bush N, Sharma YP, Prasad K, et al. Comparison of demographic profile, risk factors, and in-hospital outcome in young and old patients with acute coronary syndrome: A single-center experience. J Family Med Prim Care. 2021;10(2):871–876. doi: 10.4103/jfmpc.jfmpc_1975_20

[14] Bush N., Sharma Y.P., Prasad K., et al. Comparison of demographic profile, risk factors, and in-hospital outcome in young and old patients with acute coronary syndrome: A single-center experience // J Family Med Prim Care. 2021. Vol. 10, N 2. P. 871–876. doi: 10.4103/jfmpc.jfmpc_1975_20

[15] Qureshi WT, Kakouros N, Fahed J, Rade JJ. Comparison of Prevalence, Presentation, and Prognosis of Acute Coronary Syndromes in =35 years, 36 - 54 years, and >/= 55 years Patients. Am J Cardiol. 2021;140:1–6. doi: 10.1016/j.amjcard.2020.10.054

[16] Qureshi W.T., Kakouros N., Fahed J., Rade J.J. Comparison of Prevalence, Presentation, and Prognosis of Acute Coronary Syndromes in =35 years, 36–54 years, and >/= 55 years Patients // Am J Cardiol. 2021. Vol. 140, N. P. 1-6. doi: 10.1016/j.amjcard.2020.10.054

[17] Li YH, Ueng KC, Jeng JS, et al. 2017 Taiwan lipid guidelines for high risk patients. J Formos Med Assoc. 2017;116(4):217–248. doi: 10.1016/j.jfma.2016.11.013

[18] Li Y.H., Ueng K.C., Jeng J.S., et al. 2017 Taiwan lipid guidelines for high risk patients // J Formos Med Assoc. 2017. Vol. 116, N 4. P. 217–248. doi: 10.1016/j.jfma.2016.11.013

[19] Fasihi A, Pourhamedi S, Zahedi M, et al. Association of lymphotoxin-alpha gene polymorphisms (rs909253, rs1800683 and rs2229094) and risk of large-artery atherosclerosis stroke in Iranian population. J Gene Med. 2020;22(10):e3229. doi: 10.1002/jgm.3229

[20] Fasihi A., Pourhamedi S., Zahedi M., et al. Association of lymphotoxin-alpha gene polymorphisms (rs909253, rs1800683 and rs2229094) and risk of large-artery atherosclerosis stroke in Iranian population // J Gene Med. 2020. Vol. 22, N 10. P. e3229. doi: 10.1002/jgm.3229

[21] Kumar P, Kumar A, Misra S, et al. Association between lymphotoxin alpha (-252 A/G and -804 C/A) gene polymorphisms and risk of stroke in North Indian population: a hospital-based case-control study. Int J Neurosci. 2016;126(12):1127–1135. doi: 10.3109/00207454.2015.1134527

[22] Kumar P., Kumar A., Misra S., et al. Association between lymphotoxin alpha (-252 A/G and -804 C/A) gene polymorphisms and risk of stroke in North Indian population: a hospital-based case-control study // Int J Neurosci. 2016. Vol. 126, N 12. P. 1127–1135. doi: 10.3109/00207454.2015.1134527

[23] Ikeda S, Tanaka N, Arai T, et al. Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Atherosclerosis. 2012;221(2):458–460. doi: 10.1016/j.atherosclerosis.2012.01.003

[24] Ikeda S., Tanaka N., Arai T., et al. Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: a pathological study of 1503 consecutive autopsy cases // Atherosclerosis. 2012. Vol. 221, N 2. P. 458–460. doi: 10.1016/j.atherosclerosis.2012.01.003

[25] Nazarenko MS, Puzyrev VP, Lebedev IN, et al. Methylation profiling of human atherosclerotic plaques. Molecular Biology. 2011;45(4):610–616. (In Russ).

[26] Назаренко М.С., Пузырев В.П., Лебедев И.Н., и др. Профиль метилирования ДНК в области атеросклеротических бляшек человека //Молекулярная биология. 2011. Т. 45, № 4. С. 610–616.

[27] Kettunen T, Eklund C, Kahonen M, et al. Polymorphism in the C-reactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: The Health 2000 Survey. Scand J Clin Lab Invest. 2011;71(5):353–361. doi: 10.3109/00365513.2011.568123

[28] Kettunen T., Eklund C., Kahonen M., et al. Polymorphism in the C-reactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: The Health 2000 Survey // Scand J Clin Lab Invest. 2011. Vol. 71, N 5. P. 353–361. doi: 10.3109/00365513.2011.568123

[29] Kuhlenbaeumer G, Huge A, Berger K, et al. Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke. Cerebrovasc Dis. 2010;30(5):476–482. doi: 10.1159/000319021

[30] Kuhlenbaeumer G., Huge A., Berger K., et al. Genetic variants in the C-reactive protein gene are associated with microangiopathic ischemic stroke // Cerebrovasc Dis. 2010. Vol. 30, N 5. P. 476–482. doi: 10.1159/000319021

[31] Schneider S, Koch W, Hoppmann P, et al. Association of Toll-like receptor 4 polymorphism with age-dependent systolic blood pressure increase in patients with coronary artery disease. Immun Ageing. 2015;12:4. doi: 10.1186/s12979-015-0031-2

[32] Schneider S., Koch W., Hoppmann P., et al. Association of Toll-like receptor 4 polymorphism with age-dependent systolic blood pressure increase in patients with coronary artery disease // Immun Ageing. 2015. Vol. 12. P. 4. doi: 10.1186/s12979-015-0031-2

[33] Stanislovaitiene D, Lesauskaite V, Zaliuniene D, et al. SCARB1 single nucleotide polymorphism (rs5888) is associated with serum lipid profile and myocardial infarction in an age- and gender-dependent manner. Lipids Health Dis. 2013;12:24. doi: 10.1186/1476-511X-12-24

[34] Stanislovaitiene D., Lesauskaite V., Zaliuniene D., et al. SCARB1 single nucleotide polymorphism (rs5888) is associated with serum lipid profile and myocardial infarction in an age- and gender-dependent manner // Lipids Health Dis. 2013. Vol. 12. P. 24. doi: 10.1186/1476-511X-12-24

[35] Shirts BH, Hasstedt SJ, Hopkins PN, Hunt SC. Evaluation of the gene-age interactions in HDL cholesterol, LDL cholesterol, and triglyceride levels: the impact of the SORT1 polymorphism on LDL cholesterol levels is age dependent. Atherosclerosis. 2011;217(1):139–141. doi: 10.1016/j.atherosclerosis.2011.03.008

[36] Shirts B.H., Hasstedt S.J., Hopkins P.N., Hunt S.C. Evaluation of the gene-age interactions in HDL cholesterol, LDL cholesterol, and triglyceride levels: the impact of the SORT1 polymorphism on LDL cholesterol levels is age dependent // Atherosclerosis. 2011. Vol. 217, N 1. P. 139–141. doi: 10.1016/j.atherosclerosis.2011.03.008

[37] Kyriakou T, Pontefract DE, Viturro E, et al. Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Hum Mol Genet. 2007;16(12):1412–1422. doi: 10.1093/hmg/ddm091

[38] Kyriakou T., Pontefract D.E., Viturro E., et al. Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients // Hum Mol Genet. 2007. Vol. 16, N 12. P. 1412–1422. doi: 10.1093/hmg/ddm091

[39] Kolovou GD, Anagnostopoulou KK. Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev. 2007;6(2): 94–108. doi: 10.1016/j.arr.2006.11.001

[40] Kolovou G.D., Anagnostopoulou K.K. Apolipoprotein E polymorphism, age and coronary heart disease // Ageing Res Rev. 2007. Vol. 6, N 2. P. 94–108. doi: 10.1016/j.arr.2006.11.001

[41] Titov BV, Osmak GJ, Matveeva NA, et al. Genetic risk factors for myocardial infarction more clearly manifest for early age of first onset. Mol Biol Rep. 2017;44(4):315–321. doi: 10.1007/s11033-017-4112-5

[42] Titov B.V., Osmak G.J., Matveeva N.A., et al. Genetic risk factors for myocardial infarction more clearly manifest for early age of first onset // Mol Biol Rep. 2017. Vol. 44, N 4. P. 315–321. doi: 10.1007/s11033-017-4112-5

RIGHTS & PERMISSIONS

Eco-Vector